Xu Ling
xuling0502@mail.kiz.ac.cn
Chinese, English
Yunnan
University of Chinese Academy of Sciences
Medical School
  • 2009-09--2014-07 Bachelor's Degree: Huazhong Agricultural University
  • 2009-09--2015-01 Doctorate: University of Chinese Academy of Sciences
  • 2018-01~Present - Kunming Institute of Zoology, Chinese Academy of Sciences - Associate Researcher
  • 2015-01~2017-12 - Kunming Institute of Zoology, Chinese Academy of Sciences - Assistant Researcher
  • Chinese Society for Immunology 7th Young Scholar Award (2017): First Prize
Infection and Immunity
  • A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core, Third Author, 2022
  • Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice, Fourth Author, 2022
  • Tupaia guanylate-binding protein 1 interacts with vesicular stomatitis virus phosphoprotein and represses primary transcription of the viral genome, Third Author, 2021
  • Lower respiratory tract samples are reliable for severe acute respiratory syndrome coronavirus 2 nucleic acid diagnosis and animal model study, Tenth Author, 2021
  • Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models, Ninth Author, 2021
  • COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2, First Author, 2020
  • Tupaia OASL1 Promotes Cellular Antiviral Immune Responses by Recruiting MDA5 to MAVS, Third Author, 2020
  • An Alternative Splicing of Tupaia STING Modulated Anti-RNA Virus Responses by Targeting MDA5-LGP2 and IRF3, First Author, 2020
  • Tupaia MAVS is a dual target during HCV infection for innate immune evasion and viral replication via NF-��B, First Author, 2020
  • Tupaia MAVS Is a Dual Target during Hepatitis C Virus Infection for Innate Immune Evasion and Viral Replication via NF-kappa B, First Author, 2020
  • Extracellular Vesicle-Mediated Delivery of Circular RNA SCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models, Ninth Author, 2020
  • The 3���UTR of human MAVS mRNA contains multiple regulatory elements for the control of protein expression and subcellular localization, First Author, 2019
  • Establishment and characterization of an immortalized renal cell line of the Chinese tree shrew (Tupaia belangeri chinesis), Fourth Author, 2019
  • Evolutionary selection on MDA5 and LGP2 in the chicken preserves antiviral competence in the absence of RIG-I, First Author, 2019
  • Molecular identification and antiviral function of the guanylate-binding protein (GBP) genes in the Chinese tree shrew (Tupaia belangeri chinesis), Eleventh Author, 2019
  • The 3 ' UTR of human MAVS mRNA contains multiple regulatory elements for the control of protein expression and subcellular localization, First Author, 2019
  • Native musk and synthetic musk ketone strongly induced the growth repression and the apoptosis of cancer cells, First Author, 2016
  • Loss of RIG-I leads to a functional replacement with MDA5 in the Chinese tree shrew., First Author, 2016
  • Characterization of a MAVS ortholog from the Chinese tree shrew (Tupaia belangeri chinensis), First Author, 2015
  • Analysis of the complete mitochondrial genome and characterization of diverse NUMTs of Macaca leonina, Third Author, 2015
  • IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma, Third Author, 2014
  • 树鼩进化分类地位的分子证据, First Author, 2013
  • GENETIC ENGINEERING NEURAL STEM CELL MODIFIED BY LENTIVIRUS FOR REPAIR OF SPINAL CORD INJURY IN RATS, Sixth Author, 2006
Infection Immunity Sars-Cov-2 H1N1 Nlrp3 Inflammasome Covid-19 Tupaia Mavs Hcv Nf-Kappa B

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.